Drug Eye Africa

Burkina Faso plans first poison centre to strengthen toxicology response

Faso FDA and the Institut national de santé publique (INSP) are leading a six-day workshop to finalise documents for the creation of Burkina Faso’s first Centre Antipoison (CAP).

The workshop opened on 26 October 2026 in Koudougou and runs until 31 October 2026. Dr Sylvestre Roger Marie Tiendrébeogo, representing the Minister of Health’s cabinet, presided over the opening alongside Faso FDA Director-General Dr Arsène Ouédraogo.

The centre will address poisoning from medicines, chemicals, environmental, food and occupational sources. According to the authorities, these intoxications represent a significant concern for Burkina Faso’s health system. The facility is intended to strengthen prevention, surveillance, toxicological expertise and rapid case management.

Participants come from health, environment, agriculture, livestock, industry, water, mining, security, academia and civil society. Dr Tiendrébeogo stated that success depends on building a shared vision, defining clear responsibilities for each actor, and ensuring strong national ownership.

Dr Ouédraogo said the centre will enable rapid response to poisoning incidents, guide medical decisions and anticipate health threats.

Over six days, participants will harmonise the strategic, operational and financial framework; define coordination and monitoring mechanisms; and finalise stakeholder mapping and a funding model. The intended output is a consensual technical document ready for political validation and resource mobilisation.

Source: ANRP vigilance (Faso FDA), “Santé publique : Vers la création du premier Centre antipoison au Burkina Faso”, 27 October 2026: https://fasofda.bf/fr/appGestion/listeCategoriePublic/80987c90-56bf-4a19-b34a-edbd87bd3fb0/

About the author

Drug Eye Africa Newsroom

Drug Eye Africa Newsroom

The Drug Eye Africa newsroom reports on medicines regulation, recalls and medicine quality across the African continent. Alerts are matched against the issuing authority's published notice before publication, and corrections are timestamped on the article rather than made silently.

Regulatory alerts and news, direct to your inbox

Independent pharmaceutical news and regulatory intelligence covering Africa.

Scroll to Top